Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 27   

Articles published

AZN 3,867.91 -30.59 (-0.78%)
price chart
AstraZeneca closing Montreal R&D plant
British drug maker AstraZeneca is closing its Montreal research centre as part of a global move to cut costs and improve its productivity as it warned of a tough year ahead.
AstraZeneca to cut 7300 jobs worldwide  DigitalJournal.com
AstraZeneca Loses Ruling Over 2018 and 2021 Crestor Patents
AstraZeneca Plc lost a U.S. appeals court bid to protect its best-selling drug, Crestor, from generic competition until as late as 2021.
Astra takes brand cancer drug straight to patients
AstraZeneca Plc is selling breast cancer drug Arimidex directly to U.S. patients, offering an option for people who want to pay for the brand instead of generic versions.
Greek Doctors Battle Hospital Superbug
The drug-resistant K. pneumoniae bacteria have a genetic mutation that allows them to evade such powerful drugs as AstraZeneca Plc's Merrem and Johnson & Johnson's Doribax. A 2010 survey found 49 percent of K. pneumoniae samples in Greece aren't ...
Stock to Watch: Thorntons
This article is for information and discussion purposes only and does not form a recommendation to invest or otherwise. The value of an investment may fall.
Fakes Infiltrate Injectable Drugs
13, the FDA also alerted British drug maker AstraZeneca PLC to "a number of cases of illegal importation of oncology drugs into the U.S.
FDA Warns on Statin Drugs
AstraZeneca PLC, which makes Crestor, the only major statin still sold exclusively as a brand-name drug, said in a statement that "the cognitive issues are generally nonserious and reversible upon discontinuation" of a statin.
Special Report: A prescription for corruption
Officials at drugs companies AstraZeneca Plc, Sanofi SA and Actavis confirmed they were served in July and August 2011 with criminal indictments related to allegedly improper payments to physicians including Borojevic at his state-run institute, and ...
Ways to Bet on a Rebound in Europe
Almost a quarter of the $2.4 billion portfolio of more than 450 stocks is invested in its top 10 holdings, which at the end of December included Royal Dutch Shell PLC, Nestl�, Vodafone Group PLC and HSBC Holdings PLC. The fund is on Charles Schwab Corp ...
Pfizer eyes tie-ups with more Chinese drugmakers
Apart from Pfizer, drugmakers like AstraZeneca Plc (AZN.L), Abbott Laboratories (ABT.N) and Novartis AG NOVN.VX are taking advantage of China's lower costs and enormous pool of scientists to make big investments in R&D in China in recent years.